Article info

Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion

Authors

  1. Correspondence to Dr Sebastian Oltean, Physiology and Pharmacology, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS13NY, UK; Sebastian.oltean{at}bristol.ac.uk
View Full Text

Citation

Bullock N, Potts J, Simpkin AJ, et al
Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion

Publication history

  • Received May 11, 2015
  • Revised August 6, 2015
  • Accepted August 16, 2015
  • First published October 23, 2015.
Online issue publication 
January 21, 2016

Article Versions

  • Abstract in Romanian

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.